These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 1982548)

  • 1. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
    Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
    Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
    Yamaura T; Shibata M; Chida Y; Inaba N; Onodera S; Ohnishi H
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats].
    Yamaura T; Shibata M; Inaba N; Onodera S; Chida Y; Ohnishi H
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):401-10. PubMed ID: 1356897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
    Palacios B; Montero MJ; Sevilla MA; Román LS
    Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
    Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H; Hamada K; Taga F; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on histamine H2-receptor antagonistic property of FRG-8813, a novel anti-ulcer drug].
    Inaba N; Shibata M; Onodera S; Tanaka M; Suzuki T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):231-41. PubMed ID: 7774860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats.
    Onodera S; Shibata M; Tanaka M; Inaba N; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1995 Jun; 68(2):161-73. PubMed ID: 7563973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
    Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage.
    Ichikawa T; Ishihara K; Komuro Y; Kojima Y; Saigenji K; Hotta K
    Life Sci; 1994; 54(10):PL159-64. PubMed ID: 7509019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
    Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
    Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
    Scarpignato C; Tramacere R; Zappia L
    Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus in rats].
    Kagoshima M; Kodaira H; Shimada H
    Nihon Yakurigaku Zasshi; 1994 Nov; 104(5):379-89. PubMed ID: 7829023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
    Okabe S; Takeuchi K; Urushidani T; Takagi K
    Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.